RetroMetro_Steve

David Hoehne

Regenerative medicine is the exciting and ever dynamic branch of medicine with the purpose of replacing, repairing, renewing or engineering human cells, tissues, organs or their building blocks, utilizing the body’s innate cellular pathways for the purposes of restoring function and homeostasis in the body.

Cellutech International's history goes back to 2003 as the Human Genome Project completed the human genetic code, and information on gene expression and anti-aging became available.

Before that time, Stem Cell and Regenerative Medical research became prolific, and the learnings from each school of thought nourished the other. It was a time of escalating scientific advances in cell biology and advancing regenerative medicine.

We manufacture a connective tissue allograft derived from cryopreserved umbilical cord and Wharton’s jelly. This product is meticulously harvested from perinatal tissue of healthy human births and minimally manipulated through a proprietary process, which maintains the active biologics of placental tissue, containing significant amounts of MSCs and progenitor cells, ECM, growth factors, and cytokines. The immunomodulatory and anti-inflammatory effects of these active biologics, plus their tissue regenerative attributes, as reviewed in our White Paper, make the use of CeluCor® in regenerative medicine highly effective and safe.

Cellutech International

Logo Contest Stats

$249

Winner Selected

Contest Status

Logo Contest Compelete